|
| |
Our strategy is to utilize our core competencies to develop and market innovative products that meet important unmet medical needs. In doing so, we also aim to make our biosurgical products and our passive immunotherapy products the treatments of choice in their respective therapeutic areas. Strong partnerships that allow us to diversify our development risk and develop multiple products will be key to our success in these areas. Our strategy includes the following key elements:
- Focus on Additional Indications for Existing Products and Product Extensions.
- Develop and Launch Products that Integrate Biological Components and Medical Devices for the Biosurgical Market.
- Expand Our Core Technology.
- Utilize Strategic Collaborations to Develop New Products and Enter New Geographic Markets.
|
|
about us
